- Share this article
- Share on twitter
- Share on LinkedIn
- Share on Facebook
- Email to a friend
- Print page
Updated FSRH Clinical Guideline: Progestogen-only Pills (August 2022)
Posted 24 August 2022
Date: 24 Aug 2022
Type: FSRH Clinical Guidance and Clinical Statements
FSRH publishes its updated Clinical Guideline on Progestogen-only Pills. This guideline is also published as a supplement in BMJ Sexual and Reproductive Health (BMJ SRH) Journal.
This guideline provides evidence-based recommendations and good practice points for health professionals on the use of progestogen-only contraceptive pills. It is intended for any healthcare professional or health service providing contraceptive care in the UK.
Access the updated guideline here.
FSRH members also have access to additional member-only resources, including:
- a 15-page Progestogen-only Pills Quick Reference Summary which has been developed by the FSRH CEU to help busy clinicians give clear, accurate and safe advice on progestogen-only pills;
- answers to the CPD questions;
- a version of the guideline in which supporting evidence for the recommendations has been removed from the main text and located in an appendix for ease of reading.
FSRH members have free access to the Progestogen-only Pills webinar held on Wednesday 31 August 2022. Find out more information and reserve your place here.